|Videos|August 18, 2022
Historic and Current Treatment Options for mUM
Author(s)Sunandana Chandra, MD, MS
An expert provides an overview of the historical and currently available treatment options in metastatic uveal melanoma (mUM), including the bispecific T-cell receptor immunotherapy tebentafusp (“teh-BEN-tah-fuhsp”).
Advertisement
Episodes in this series
Advertisement
Related Content
Advertisement
Advertisement
Trending on CURE
1
5 Years of Prostate Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
2
What Your Friend with Cancer REALLY Needs
3
Getting on My Ovarian Cancer Awareness Soap Box Again Because I Love My Daughter
4
FDA Grants Final Approval to OMCAZIO, a New Capsule Formulation of Cabozantinib
5